Background: Ventilator Associated Pneumonia (VAP) is defined as nosocomial pneumonia develops 48 hours or more after initiation of mechanical ventilation. Hospital acquired infection (HAI) is the second most common infection for the pediatric population. VAP about 20% of all HAI among patients in NICU & PICU. Higher mortality and morbidity rate for mechanically ventilated pediatric patients with VAP compared to those without VAP. Few data & very few researches exist regarding VAP in pediatric patients to identify risk factors of VAP and that might be helpful for preventing VAP. This study was done to find out the predictors of VAP of neonate in Neonatal and Pediatric Intensive Care Unit. Methodology: A prospective cohort study was carried out in NICU & PICU of Dhaka Shishu (Children) Hospital, Dhaka. Neonates those not had pneumonia; requiring mechanical ventilation at least 48 hours in the NICU or PICU were taken for this study. Then VAP patients were selected by radiographic changes after 48 hours of intubation.
Introduction
Ventilator Associated Pneumonia (VAP) is defined as nosocomial pneumonia develops 48 hours or more after initiation of mechanical ventilation. Hospital acquired pneumonia (HAI) is the second most common infection after bloodstream infection for the pediatric population. VAP accounts for about 20% of all HAI among patients in pediatric intensive care unit (PICU). Furthermore, some data suggested higher mortality rate for mechanically ventilated pediatric patients with VAP compared to those without VAP.
Hospital costs and the length of ICU stay were significantly increased for pediatric patients with VAP compared to those without VAP. 1 The epidemiology, pathogenesis, and outcome of VAP are well described in adults. However, few data exist regarding VAP in pediatric patients. Because of different anatomy, physiology and underlying illnesses from adults, it is important to identify specific prevention for this population in preventing VAP. Till now, there have been very few researches about risk factors of VAP in PICU. However, these results indicated that risk factors were varied or contradictory. Reintubation and transport in from other PICU were independent predictors of VAP. 2 However, only prior antibiotic therapy was independent predictors of VAP. 3 Incidence of VAP ranges from 9% to 70%. Mortality ranges from 13% to 55%. VAP increases average hospital stay from 6 days to more than 30 days, and also increases costs up to $ 50,000 per hospital stay. 4 VAP is the second most common Nosocomial infection after urinary tract infection in PICU patients, accounting for 20% of nosocomial infection in this population. The pneumonia rate was 6-21 fold higher for patients receiving ventilator support compared to those not requiring mechanical ventilation. Also intubations independently increase the risk of nosocomial pneumonia seven fold. 5 Langer and co-workers divided VAP into early onset VAP which occurs within 5 days of mechanical ventilation and late onset VAP which develops on equal or more than 5 days after initiation of mechanical ventilation. The importance of segregating VAP into early and late is that, the pathogenesis and microorganisms responsible for these two groups, along with the outcome of these two groups are different, and hence the therapeutic implications also differ. Early onset VAP results from aspiration of endogenous community acquired organisms e.g. S. pneumoniae, H. influenzae, and other organisms (aerobic gram negative bacilli). Late onset VAP is more severe and results usually from aspiration of gastric/oropharyngeal secretions, and is caused by potentially drug resistant organisms like methicillin resistant Staphylococcus aureus (MRSA) and Pseudomonas. 6 When a microorganism is isolated from a blood culture in a patient with pneumonia, that organism is the likely etiological pathogen. Even in complex circumstances, such as nosocomial VAP, if a non pulmonary infection is absent, then a positive blood culture is considered presumptive evidence of an exact etiological diagnosis. 7 Ventilator Associated Pneumonia (VAP) is one of the leading causes of death among hospital acquired infections. The patient develops a shadow on the lungs, such as patchy opacity, consolidation, cavitation, and/or pneumatoceles, along with fever, leukopenia or leukocytosis and/or new onset of purulent sputum, change in character of sputum, increased respiratory secretions, or increased suctioning requirements. There may also be a new onset of or worsening cough, dyspnea, or tachypnea, associated with rales or bronchial breath sounds, worsening gas exchange (O 2 desaturations), increased oxygen requirements or increased ventilation demand. 6 The primary risk factor for the development of VAP is mechanical ventilation and improper care after intubation. Critically ill patients especially intubated patients are at the higher risk of acquiring VAP.
The incidence of VAP ranges from 10-65 % of intubated patients depending on the risk factors. Risk factors were reintubation, age, prior antibiotics, and duration of Intermittent Positive Pressure Ventilation (IPPV). The mortality of VAP ranges from 13 % to 55 %. VAP is commonly caused by antibiotic-resistant nosocomial organisms like Pseudomonas aeruginosa, Eschericha coli, Klebsiella pneumoniae, Acinetobacter species and Staphylococcus species. 8 CDC guidelines for the prevention of VAP include recommendations for nursing care. One recommendation for staff is to participate in educational interventions since educational interventions can reduce VAP rates. 9
Methodology
Prospective cohort study. NICU and PICU of Dhaka Shishu (Children) Hospital, Dhaka from October 2015 to April 2017. Age 0-28 days and neonates required mechanical ventilation at least 48 hours in the NICU or PICU was included in this study. Neonates required mechanical ventilation in the NICU or PICU were taken for this study. Then VAP patients were selected after 48 hours of intubation by radiographic change.
Portable chest x-ray was done by an expert technician after 48 hours, and as required after initiation of mechanical ventilation and follow upto development of Ventilator Associated Pneumonia. Data was collected including demographics, medical history, medical documents, the need for mechanical ventilation, duration of ventilation and previous ICU admission with treatment received. Bacteremia was detected by CBC with PBF, CRP (Haematological scoring system), 10, 11 Blood Culture & Sensitivity, tracheal aspirate for Culture & Sensitivity. Under all aseptic precaution blood sample was collected by an expert ICU staff from peripheral accessible vein. Hospital discharge status was noted for all patients.
Statistical analysis were carried out using the Statistical Package for Social Sciences version 23.0 for Windows (SPSS Inc., Chicago, Illinois, USA). The quantitative observations were indicated by frequencies and percentages. Relative risk measurement with 95% CI limit was done for risk factor. P values <0.05 were considered as statistically significant.
Results
More than half (51.4%) of the neonates belonged to age group 0-10 days. Males were predominant in this study comprising of 73.6% and females were 26.4%. Male female ratio was 2.8:1 (Table-I (Table-II) . Fifty seven (79.2%) neonates had VAP (Fig.-1) . (Table-V) .
Discussion
This prospective cohort study was carried out in NICU and PICU of Dhaka Shishu (Children) Hospital, Dhaka. VAP patients were selected after 48 hours of intubation by radiographic change. Portable chest xray was done by an expert technician after 48 hours and as required after initiation of mechanical ventilation.
In this study it was observed that more than half (51.4%) neonates belonged to age group 0-10 days develops VAP. The study showed postnatal age on admission was found to be 3.26±4.0 days. 6 In our study it was observed that male were predominant in this study which comprised 73.6% and females were 26.4%. Male female ratio was 2.8:1. In comparison to other study 73.0% were males. 6 Another study showed a majority of 58.0% were male babies. 2 Once reported that 50.2% patients were male and 49.8% were female. 12 In this series it was observed that more than half (51.4%) neonates were gestational age 34 to <37 weeks. Similar result showed that 56.67% prematurity (<37 weeks). 6 Mean gestational age was 27.1±2.3 weeks in the VAP group. 13 Regarding admission weight in this study, weight less than 2.5 kg neonates were 69.4% and weight equal or more than 2.5 kg neonates were 30.6% among neonates. In the cross sectional survey by VAP rates were highest for the 1,001 gm to 1,500 gm. 5 Very low birth weight (birth weight <1.5 kg) were found to be 33.33%. 6 Another reported that most of the (8677) very low birth weight infants from 52 neonatology departments in Germany developed VAP. 14 In this study it was observed that neonates transferred from other NICU & PICU were 25(34.7%) developed VAP. Neonates in isolation unit who were transferred from a neonatal intensive care unit (NICU) developed bacterial infections. 15 In our study it was observed that 29(40.3%) neonates had prolonged mechanical ventilation. Patients with nosocomial pneumonia after prolonged mechanical ventilation were 63.6%. 5 In this study it was observed that 26(36.1%) neonates had reintubation. Reintubation was found in 60.0% and also 13.7% patients. 6, 2 In our study it was observed that 53(73.6%) neonates having prior use of antibiotics developed VAP. A prospective cohort study at an academic tertiary care center performed in a PICU found that over half (56.6%) of all patients receiving antibiotics developed VAP. 16 Regarding nosocomial infection of the neonates, it was observed that 55(76.4%) neonates had nosocomial infection. Nosocomial infection was found as a risk factor not only for VAP, but also for most of the hospital admitted patients found in many studies. But exact percentages were not mentioned for developing VAP. Surveillance studies of nosocomial infections in NICU patients indicate that pneumonia comprises 6.8 to 32.3% of nosocomial infections. 17 In this study shows tracheal aspirate C/S positive was found in 8 ( 12 The most common pathogens isolated in the neonatal population are Pseudomonas aeruginosa and Staphylococcus aureus. 18 However, isolation of other microorganisms such as Klebsiella pneumoniae and Escherichia coli has also been reported. 6, 19 In this study blood C/S positive was found in 10(13.9%) cases. Eleven percent blood culture positive by another authors which is similar to our study. 11 Several prospective cohort studies described risk factors for pediatric VAP. In a prospective cohort study at a tertiary care center; transfer out of the PICU (OR, 8.90; 95% CI, 3.82 to 20.74), and reintubation (OR, 2.71; 95% CI, 1.18 to 6.21) were all independent predictors of pediatric VAP. 2 The same also found that primary blood stream infections were associated with the development of VAP. Another prospective cohort study identified prior antibiotic use (OR, 2.45; 95% CI: 1.112 to 5.405) as being independent predictor of pediatric VAP. 3 Several factors identified associated with increased risk of developing VAP: reintubation (OR, 4.95; 95% CI: 3.48 to 7.04; P= 0.000012) and mechanical ventilation for >3 days (OR, 1.17; 95% CI: 1.15 to 1.19; P= 0.015). 21 In the current study, common indication of ventilation were perinatal asphyxia, neonatal sepsis, preterm LBW and some post operative surgical cases. Recovery or discharge with advise were 7(9.7%), discharge with risk bond were 27(37.5%) due to financial problem and mortality were 38(52.8%).
Another study found that 13-55% mortality. 8 Although among the mortality of VAP some cases were associated with some comorbidities.
Conclusion
Age group 11-20 days, gestational age less than 37 weeks, weight less than 2.5 kg, transferred from other NICU & PICU, prolonged mechanical ventilation, reintubation and nosocomial infection were regarded as predictors for Ventilator Associated Pneumonia and those predictors were significantly associated with developing Ventilator Associated Pneumonia.
